Moderna Partners with Baxter BioPharma Solutions to Supply 60-90 million Vaccine Doses this Year
Boston Herald – Moderna is bolstering its coronavirus vaccine manufacturing efforts with an agreement with Baxter BioPharma Solutions to provide fill and finish services for 60-90 million vaccine doses this year. “We have seen a remarkable demonstration of scientific and health-care expertise in the effort to develop vaccines for COVID-19,” said Marie Keeley, vice president of…